{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:04:00Z","timestamp":1788444240061,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.nucmedbio.2023.108366","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T02:58:53Z","timestamp":1689303533000},"page":"108366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2"],"prefix":"10.1016","volume":"122-123","author":[{"given":"Christian Werner","family":"Wichmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid Julienne Georgette","family":"Burvenich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Rigopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme Joseph","family":"O'Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia Jie","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Kong","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona Elizabeth","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabendu","family":"Pore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Coats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Mark","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2023.108366_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev-med-050311-201823","article-title":"Antibody-drug conjugates in cancer therapy","volume":"64","author":"Sievers","year":"2013","journal-title":"Annu Rev Med"},{"issue":"Supplement 1","key":"10.1016\/j.nucmedbio.2023.108366_bb0010","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1182\/blood-2018-99-119836","article-title":"Discovery and development of MEDI7247, a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2, for treating hematological cancers","volume":"132","author":"Pore","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.nucmedbio.2023.108366_bb0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1158\/1078-0432.CCR-14-2093","article-title":"Potential mechanisms for thrombocytopenia development with trastuzumab emtansine (T-DM1)","volume":"21","author":"Uppal","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2023.108366_bb0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3390\/cancers13020203","article-title":"ASCT2 and LAT1 contribution to the hallmarks of cancer: from a molecular perspective to clinical translation","volume":"13","author":"Lopes","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"837","key":"10.1016\/j.nucmedbio.2023.108366_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejphar.2018.07.007","article-title":"The role of ASCT2 in cancer: a review","volume":"15","author":"Liu","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2023.108366_bb0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3389\/fcell.2018.00096","article-title":"The human SLC1A5 (ASCT2) amino acid transporter: from function to structure and role in cell biology","volume":"6","author":"Scalise","year":"2018","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"10.1016\/j.nucmedbio.2023.108366_bb0035","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/14728222.2019.1627328","article-title":"ASCT2: a potential cancer drug target","volume":"23","author":"Wahi","year":"2019","journal-title":"Expert Opin Ther Targets"},{"issue":"24","key":"10.1016\/j.nucmedbio.2023.108366_bb0040","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1038\/onc.2015.381","article-title":"ASCT2\/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer","volume":"35","author":"Van Geldermalsen","year":"2016","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.nucmedbio.2023.108366_bb0045","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00726-017-2436-z","article-title":"GPNA inhibits the sodium-independent transport system L for neutral amino acids","volume":"49","author":"Chiu","year":"2017","journal-title":"Amino Acids"},{"issue":"25","key":"10.1016\/j.nucmedbio.2023.108366_bb0050","doi-asserted-by":"crossref","first-page":"13194","DOI":"10.1074\/jbc.M115.700534","article-title":"Deletion of amino acid transporter ASCT2 (SLC1A5) reveals an essential role for transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to sustain glutaminolysis in cancer cells","volume":"291","author":"Broer","year":"2016","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.nucmedbio.2023.108366_bb0055","first-page":"1499","article-title":"An anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models","volume":"8","author":"Osanai-Sasakawa","year":"2018","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.nucmedbio.2023.108366_bb0060","article-title":"MEDI7247, a novel pyrrolobenzodiazepine ADC targeting ASCT2 with potent in vivo activity across a spectrum of hematological malignancies","volume":"78(13_Supplement):LB-298","author":"Monks","year":"2018","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.nucmedbio.2023.108366_bb0065","first-page":"342","article-title":"FDA approves PI3K inhibitor for a rare immune disorder","volume":"22","author":"Mullard","year":"2023","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.nucmedbio.2023.108366_bb0070","doi-asserted-by":"crossref","first-page":"252","DOI":"10.37349\/etat.2022.00082","article-title":"Antibody-drug conjugates: beyond current approvals and potential future strategies","volume":"3","author":"Menon","year":"2022","journal-title":"Explor Target Antitumor Ther"},{"issue":"6","key":"10.1016\/j.nucmedbio.2023.108366_bb0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41571-021-00470-8","article-title":"Unlocking the potential of antibody-drug conjugates for cancer therapy","volume":"18","author":"Drago","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.nucmedbio.2023.108366_bb0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/1541-7786.MCR-19-0582","article-title":"Antibody-drug conjugates: a comprehensive review","volume":"18","author":"Khongorzul","year":"2020","journal-title":"Mol Cancer Res"},{"issue":"4","key":"10.1016\/j.nucmedbio.2023.108366_bb0085","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrc3236","article-title":"Antibody therapy of cancer","volume":"12","author":"Scott","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.nucmedbio.2023.108366_bb0090","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2967\/jnumed.119.239558","article-title":"The role of 89Zr-immuno-PET in navigating and derisking the development of biopharmaceuticals","volume":"62","author":"van Dongen","year":"2021","journal-title":"J Nucl Med"},{"issue":"12","key":"10.1016\/j.nucmedbio.2023.108366_bb0095","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.3390\/ijms21124309","article-title":"Current perspectives on 89Zr-PET imaging","volume":"21","author":"Yoon","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.nucmedbio.2023.108366_bb0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-060478","article-title":"89Zirconium-labelled girentuximab (89Zr-TLX250) PET in urothelial cancer patients (ZiPUP): protocol for a phase I trial of a novel staging modality for urothelial carcinoma","volume":"12","author":"Al-Zubaidi","year":"2022","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.nucmedbio.2023.108366_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nucmedbio.2012.08.004","article-title":"PET imaging with 89Zr: from radiochemistry to the clinic","volume":"40","author":"Deri","year":"2013","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2023.108366_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0022-1759(84)90435-6","article-title":"Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess","volume":"72","author":"Lindmo","year":"1984","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.nucmedbio.2023.108366_bb0115","first-page":"4474","article-title":"Specific localisation, gamma camera imaging and intracellular trafficking of radiolabelled anti-GD3 monoclonal antibody in a melanoma xenograft","volume":"61","author":"Lee","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2023.108366_bb0120","doi-asserted-by":"crossref","first-page":"974","DOI":"10.2967\/jnumed.115.169839","article-title":"Molecular imaging and quantitation of EphA2 expression in xenograft models with 89Zr-DS-8895a","volume":"57","author":"Burvenich","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2023.108366_bb0125","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.7150\/thno.25575","article-title":"Molecular imaging of T cell co-regulator factor B7-H3 with 89Zr-DS-5573a","volume":"8","author":"Burvenich","year":"2018","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.nucmedbio.2023.108366_bb0130","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1158\/0008-5472.CAN-10-2277","article-title":"Influence of affinity and antigen internalization on the uptake and penetration of anti-HER2 antibodies in solid tumors","volume":"71","author":"Rudnick","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2023.108366_bb0135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2249.1991.tb05693.x","article-title":"Kupffer cell depletion in vivo results in clearance of large-sized IgA aggregates in rats by liver endothelial cells","volume":"85","author":"Bogers","year":"1991","journal-title":"Clin Exp Immunol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805123000549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805123000549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:31:12Z","timestamp":1760848272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805123000549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":27,"alternative-id":["S0969805123000549"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2023.108366","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2023.108366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108366"}}